Healthcare

in committee · United States · Senate Apr 16, 2026

S 4327: Securing America’s Drug Supply from Communist China Act

This bill requires the U.S. Food and Drug Administration to review new drug applications from companies based in China to determine if they are affiliated with the Chinese government, Communist Party, or military. If an application comes from such an affiliated entity, the FDA will deny approval for the drug, and U.S. Customs and Border Protection will refuse entry and destroy any imported drugs from these sponsors. The law also allows for a process where affected companies can prove they are no longer affiliated or sell their drug rights to a non-affiliated company within 180 days to avoid having their products blocked. Additionally, the bill authorizes $5 million in funding to carry out these review and enforcement activities.

Topics ✗ HealthcareOpposes HealthcareBill restricts drug access by denying FDA approval and blocking imports from Chinese-affiliated entities, limiting patient access to potential treatments.85% confidence

Track

in committee · United States · House Apr 30, 2026

HR 8603: Dismemberment Abortion Ban Act of 2026

HR 8603, the Dismemberment Abortion Ban Act of 2026, prohibits physicians from performing abortions that involve dismembering an unborn child and extracting it piece by piece or crushed from the uterus. The law allows exceptions only when the procedure is necessary to save the mother's life, while explicitly permitting other abortion methods for reasons such as rape or incest. It imposes criminal penalties of up to two years in prison or fines on physicians who violate the ban and creates a civil lawsuit system where women or parents of minors can seek monetary damages and attorney fees against providers. The bill also defines an 'unborn child' as a human organism from fertilization until birth and clarifies that the woman undergoing the procedure cannot be prosecuted or held financially liable.

Topics ✗ HealthcareOpposes HealthcareBill restricts physician access to specific abortion procedures, limiting patient care options and imposing penalties on medical professionals.95% confidence

Sub-Topics Women's Health

Track

in committee · United States · Senate Apr 16, 2026

S 4329: Title X Abortion Provider Prohibition Act

This bill amends the Title X family planning program to prohibit the use of federal funds for entities that perform or financially support abortions. It allows exceptions for cases involving rape, incest, or life-threatening medical conditions, while also permitting hospitals to receive funding as long as they do not give those funds to non-hospital abortion providers. To enforce these rules, the bill requires the Secretary of Health and Human Services to submit annual reports detailing which organizations receive grants and the specific number of abortions performed under the medical and criminal exceptions.

Topics ✗ HealthcareOpposes HealthcareBill restricts federal funding for abortion services, limiting patient access and reducing benefits under the Title X program.95% confidence

Sub-Topics Hospitals Women's Health

Track

in committee · United States · House May 15, 2026

HR 8857: Next GEN Act of 2026

The Next GEN Act of 2026 modifies the Drug Price Negotiation Program to include a specific category of medications called engineered cyclic peptides. This change extends the time before these drugs can be negotiated for lower prices from seven years to eleven years. The bill defines these peptides as synthetic, amino acid-based drugs that are self-administered and created using genetic library screening methods. By adjusting the timeline, the legislation directly affects pharmaceutical companies and the government agencies responsible for setting drug prices under the program.

Topics ✗ HealthcareOpposes HealthcareBill delays drug price negotiations for specific medications, restricting patient access to lower costs and weakening healthcare affordability.85% confidence

Sub-Topics Prescription Drugs

Track

in committee · United States · Senate Jun 9, 2026

SJRES 192: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".

This joint resolution seeks to reject a specific federal rule issued by the Centers for Medicare & Medicaid Services regarding the WISeR Model, which was designed to reduce wasteful spending by requiring prior authorization for select Medicare services. If passed, the measure would legally nullify the rule, preventing the Centers for Medicare & Medicaid Services from enforcing the new prior authorization requirements on healthcare providers. The bill directly affects Medicare beneficiaries and medical facilities that would otherwise have to comply with these administrative changes. By invoking the Congressional Review Act, the legislation aims to stop the implementation of the policy without altering the underlying statute governing Medicare.

Topics ✗ HealthcareOpposes HealthcareBill nullifies a rule requiring prior authorization, which limits patient access to services and restricts healthcare program enforcement.90% confidence

Sub-Topics Medicaid Medicare

Track

in committee · United States · Senate May 12, 2026

S 4501: BACK OFF Act

The BACK OFF Act establishes new grounds for denying entry and deporting individuals who attempt to enter the United States specifically to give birth and secure citizenship for their children. It mandates that immigration officers and consular officials require medical examinations for women of childbearing age to assess the likelihood of childbirth during their stay, with potential visa denials based on these findings. The legislation also creates a specialized taskforce within the Department of Homeland Security to investigate and prosecute those who facilitate birth tourism, while imposing severe criminal penalties, including up to 25 years in prison, on individuals who assist in these activities. Additionally, the bill restricts judicial review of birth tourism cases and authorizes the suspension of visas from countries that refuse to accept their citizens for removal.

Topics ✗ HealthcareOpposes HealthcareBill restricts access to reproductive healthcare services by mandating medical exams to deny entry for childbirth.90% confidence ✗ ImmigrationOpposes ImmigrationBill restricts immigrant access by creating new grounds for deportation and denying entry to those seeking birth tourism.95% confidence

Sub-Topics Citizenship & Naturalization

Track

in committee · United States · House May 19, 2026

HJRES 187: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".

This joint resolution expresses Congress's disapproval of a Centers for Medicare & Medicaid Services rule that requires doctors to obtain prior authorization for certain medical services under the WISeR Model. The bill directly affects healthcare providers and patients by seeking to cancel the rule, which would otherwise mandate that specific services be approved before they are delivered. If passed, the provision would render the rule ineffective, preventing the new prior authorization requirements from taking effect. This action is part of a standard legislative process used to reject federal regulations without needing to pass a new law.

Topics ✗ HealthcareOpposes HealthcareBill opposes a CMS rule requiring prior authorization, which limits patient access to services and restricts healthcare provider flexibility.95% confidence

Sub-Topics Medicaid Medicare

Track

in committee · United States · House Apr 15, 2026

HR 8293: Abolish the CMMI Act

This bill, titled the "Abolish the CMMI Act," would eliminate the Center for Medicare and Medicaid Innovation (CMMI). The CMMI is responsible for developing and testing new healthcare payment and service delivery models for Medicare and Medicaid programs. Its abolition would directly affect Medicare and Medicaid beneficiaries and healthcare providers who participate in or are impacted by these innovative models. The bill achieves this by repealing Section 1115A of the Social Security Act, which established the CMMI.

Topics ✗ HealthcareOpposes HealthcareBill eliminates CMMI, which develops innovative healthcare payment models for Medicare/Medicaid, restricting healthcare program improvements and limiting patient access to new service delivery models.95% confidence

Sub-Topics Medicaid Medicare

Track

in committee · United States · House Mar 12, 2026

HR 7902: Safeguarding Women from Chemical Abortion Act

This bill, titled the Safeguarding Women from Chemical Abortion Act, aims to revoke federal approval for the drug mifepristone (also known as RU-486) for use in terminating pregnancies. If enacted, the Food and Drug Administration's approval for mifepristone for this indication would be withdrawn within 14 days, making its introduction into interstate commerce for pregnancy termination a violation of federal law. Additionally, the bill establishes a new federal right for individuals to sue manufacturers of mifepristone if they experience bodily injury or harm to mental health attributed to its use for pregnancy termination. This legislation directly affects drug manufacturers, distributors, healthcare providers, and individuals seeking or having used medication abortion.

Topics ✗ HealthcareOpposes HealthcareBill restricts access to abortion medication by revoking FDA approval, limiting patient access to reproductive healthcare services.95% confidence

Sub-Topics Mental Health Women's Health

Track

in committee · United States · House Apr 20, 2026

HR 8366: PEARL Act

The PEARL Act (HR 8366) aims to protect pharmacists who have sincerely held religious beliefs against dispensing or selling the abortion-inducing drugs mifepristone and misoprostol. It specifies that pharmacists, whether employed by private businesses or government agencies, cannot be required to dispense these drugs or be subject to punishment, such as license revocation or loss of federal funding, for refusing to do so based on their religious beliefs. The bill also establishes a private right of action, allowing pharmacists who are compelled or penalized in violation of this act to file a civil lawsuit in federal court for injunctive relief.

Topics ✗ HealthcareOpposes HealthcareBill restricts pharmacists' ability to dispense abortion-inducing drugs, limiting patient access to reproductive healthcare services and imposing restrictions on healthcare providers.85% confidence

Sub-Topics Women's Health

Track